Acticor biotech raised €153M in a Series B round in Nov 2018. The company is based in Paris, France. Investors in the round: Newton Biocapital. Data as of 7 Aug 2026.
Reported in EUR — no conversion. €153M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
